"Mercy Cancer Center - Sacramento is a cancer center that offers many services, including medical oncology, advanced diagnostic imaging, and radiation oncology. Visit Mercy Cancer Center - Sacramento located at 3301 C St, Sacramento, CA. This Sacramento cancer center is one of the best in California. As part of the Dignity Health network, Mercy Cancer Center - Sacramento is dedicated to delivering high quality, compassionate care and access to Sacramento and nearby communities."

During the past decade, Mercy Cancer Center - Sacramento conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 6 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Cancer Center - Sacramento" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "NRG Oncology" with 4 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "GOG Foundation" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Cancer Center - Sacramento" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Cancer Center - Sacramento" are "Ovarian Seromucinous Carcinoma" (3 trials), "Recurrent Fallopian Tube Carcinoma" (3 trials), "Recurrent Ovarian Carcinoma" (3 trials), "Recurrent Primary Peritoneal Carcinoma" (3 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "Mercy Cancer Center - Sacramento" in a lesser frequency.

Most popular intervention types in "Mercy Cancer Center - Sacramento" are "Drug" (22 trials), "Other" (18 trials), "Biological" (5 trials), "Procedure" (5 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Paclitaxel" (6 trials), "Quality-of-Life Assessment" (6 trials), "Carboplatin" (5 trials) and "Computed Tomography" (5 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Cancer Center - Sacramento" are 17 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Cancer Center - Sacramento". undefined are not yet recruiting, 7 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mercy Cancer Center - Sacramento, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Cancer Center - Sacramento, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".